ICD-10-CM Billable Code

H40.41

Glaucoma secondary to eye inflammation, right eye

Clinical Classification Guidelines

Medical Intelligence & Overview

Glaucoma secondary to eye inflammation, specifically affecting the right eye, is a form of secondary glaucoma caused by inflammation within the eye that leads to increased intraocular pressure (IOP). This condition can damage the optic nerve, leading to vision loss if untreated. It is characterized by elevated eye pressure resulting from inflammatory processes or associated complications within the eye structures. Recognizing this type of glaucoma early is essential to prevent irreversible damage to vision.

Causes & Symptoms

Clinical Causes: Inflammatory eye conditions such as uveitis or iridocyclitis Eye infections leading to inflammatory responses Chronic ocular inflammation due to autoimmune disorders Post-surgical inflammation or trauma Inflammation from other ocular diseases that disrupt normal fluid drainage Complications following eye surgeries or injuries

Key Symptoms: Gradual or sudden loss of vision in the right eye Eye redness and tenderness Eye pain or discomfort Halo or rainbow-colored glare around lights Increased sensitivity to light (photophobia) Seeing floaters or dark spots Nausea or vomiting in severe cases due to increased eye pressure

Diagnostic & Treatment

Diagnosis Path: Diagnosing glaucoma secondary to eye inflammation involves a comprehensive eye examination, including measurements of intraocular pressure, assessment of the optic nerve, and evaluation of the anterior chamber of the eye. Additional diagnostic tests may include gonioscopy to examine the drainage angle and ocular imaging techniques such as optical coherence tomography (OCT). A detailed medical history focusing on inflammatory eye diseases or recent eye trauma helps establish the causative link. The healthcare provider may also perform a slit-lamp examination to observe signs of inflammation and structural changes in the eye.

Treatment Protocols: Management of glaucoma secondary to eye inflammation aims to control intraocular pressure and address the underlying inflammation. Typical treatment strategies include: - **Anti-inflammatory medications:** Corticosteroids or non-steroidal anti-inflammatory drugs (NSAIDs) to reduce eye inflammation. - **IOP-lowering medications:** Eye drops or oral medications such as prostaglandin analogs, beta-blockers, alpha agonists, or carbonic anhydrase inhibitors. - **Treating underlying causes:** Addressing infections or autoimmune conditions with appropriate therapies. - **Laser or surgical interventions:** Procedures such as trabeculectomy or drainage implant surgeries if medications are insufficient. Regular follow-up appointments are critical to monitor intraocular pressure and prevent optic nerve damage. The goal of treatment is to preserve vision and alleviate symptoms caused by increased eye pressure.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is H40.41 a billable ICD-10 code?
Yes, H40.41 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report H40.41?
Clinical documentation must specify the nature of Glaucoma secondary to eye inflammation, right eye and any associated comorbidities for accurate reporting.

Cite this Clinical Reference